BioCentury
ARTICLE | Company News

Besins Healthcare, Atossa Genetics deal

June 22, 2015 7:00 AM UTC

Besins granted Atossa exclusive, worldwide rights to develop and commercialize afimoxifene gel to treat and prevent hyperplasia of the breast. Besins is eligible to receive 8-9% royalties for 15 year...